Original paper
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
Paper Details
Title
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
Published Date
Nov 6, 2018
Journal
Volume
19
Issue
12
Pages
1654 - 1667
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History